Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 229

1.

Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.

Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, Seron P, Ahmed SH, Rosengren A, Kelishadi R, Rahman O, Swaminathan S, Iqbal R, Gupta R, Lear SA, Oguz A, Yusoff K, Zatonska K, Chifamba J, Igumbor E, Mohan V, Anjana RM, Gu H, Li W, Yusuf S; Prospective Urban Rural Epidemiology (PURE) Study investigators.

Lancet. 2015 May 12. pii: S0140-6736(14)62000-6. doi: 10.1016/S0140-6736(14)62000-6. [Epub ahead of print]

PMID:
25982160
2.

Validation of the Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (from the COURAGE Trial).

Bradley SM, Chan PS, Hartigan PM, Nallamothu BK, Weintraub WS, Sedlis SP, Dada M, Maron DJ, Kostuk WJ, Berman DS, Teo KK, Mancini GB, Boden WE, Spertus JA.

Am J Cardiol. 2015 Apr 17. pii: S0002-9149(15)01101-7. doi: 10.1016/j.amjcard.2015.03.057. [Epub ahead of print]

PMID:
25960375
3.

Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Kohl M, Heinze G, Teo KK, Rosengren A, Pogue J, Gao P, Gerstein H, Yusuf S, Oberbauer R, Mann JF; ONTARGET Investigators.

Kidney Int. 2015 Apr;87(4):784-91. doi: 10.1038/ki.2014.370. Epub 2014 Dec 10.

PMID:
25493953
4.

Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery position statement on revascularization--multivessel coronary artery disease.

Teo KK, Cohen E, Buller C, Hassan A, Carere R, Cox JL, Ly H, Fedak PW, Chan K, Légaré JF, Connelly K, Tanguay JF, Ye J, Gupta M, John Mancini GB, Dagenais G, Williams R, Teoh K, Latter DA, Townley R, Meyer SR.

Can J Cardiol. 2014 Dec;30(12):1482-91. doi: 10.1016/j.cjca.2014.09.034. Epub 2014 Oct 5. Review.

PMID:
25475448
5.

The mini-mental state examination, clinical factors, and motor vehicle crash risk.

Joseph PG, O'Donnell MJ, Teo KK, Gao P, Anderson C, Probstfield JL, Bosch J, Khatib R, Yusuf S.

J Am Geriatr Soc. 2014 Aug;62(8):1419-26. doi: 10.1111/jgs.12936. Epub 2014 Jul 15.

PMID:
25040793
6.

Circulating levels of matrix gla protein and progression of aortic stenosis: a substudy of the Aortic Stenosis Progression Observation: Measuring Effects of rosuvastatin (ASTRONOMER) trial.

Capoulade R, Côté N, Mathieu P, Chan KL, Clavel MA, Dumesnil JG, Teo KK, Tam JW, Fournier D, Després JP, Pibarot P; ASTRONOMER Investigators.

Can J Cardiol. 2014 Sep;30(9):1088-95. doi: 10.1016/j.cjca.2014.03.025. Epub 2014 Mar 24.

PMID:
25015689
7.

Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study.

Gupta R, Islam S, Mony P, Kutty VR, Mohan V, Kumar R, Thakur J, Shankar VK, Mohan D, Vijayakumar K, Rahman O, Yusuf R, Iqbal R, Shahid M, Mohan I, Rangarajan S, Teo KK, Yusuf S.

Eur J Prev Cardiol. 2014 Jun 18. pii: 2047487314540386. [Epub ahead of print]

PMID:
24942224
8.

Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control study.

Leong DP, Smyth A, Teo KK, McKee M, Rangarajan S, Pais P, Liu L, Anand SS, Yusuf S; INTERHEART Investigators.

Circulation. 2014 Jul 29;130(5):390-8. doi: 10.1161/CIRCULATIONAHA.113.007627. Epub 2014 Jun 13.

PMID:
24928682
9.

The relationship between estimated sodium and potassium excretion and subsequent renal outcomes.

Smyth A, Dunkler D, Gao P, Teo KK, Yusuf S, O'Donnell MJ, Mann JF, Clase CM; ONTARGET and TRANSCEND investigators.

Kidney Int. 2014 Dec;86(6):1205-12. doi: 10.1038/ki.2014.214. Epub 2014 Jun 11.

PMID:
24918156
10.

Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial.

Teo KK, Pfeffer M, Mancia G, O'Donnell M, Dagenais G, Diaz R, Dans A, Liu L, Bosch J, Joseph P, Copland I, Jung H, Pogue J, Yusuf S; Aliskiren Prevention of Later Life Outcomes trial Investigators.

Eur Heart J. 2014 Jul;35(26):1743-51. doi: 10.1093/eurheartj/ehu079. Epub 2014 Mar 9.

PMID:
24616335
11.

Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema.

Straka B, Nian H, Sloan C, Byrd JB, Woodard-Grice A, Yu C, Stone E, Steven G, Hartert T, Teo KK, Pare G, McCarty CA, Brown NJ.

J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):468-73.e1-4. doi: 10.1016/j.jaip.2013.05.003. Epub 2013 Jun 21.

12.

Sodium intake and renal outcomes: a systematic review.

Smyth A, O'Donnell MJ, Yusuf S, Clase CM, Teo KK, Canavan M, Reddan DN, Mann JF.

Am J Hypertens. 2014 Oct;27(10):1277-84. doi: 10.1093/ajh/hpt294. Epub 2014 Feb 7.

PMID:
24510182
13.

Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND.

Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, Yusuf S, Böhm M.

Clin Res Cardiol. 2014 Feb;103(2):149-59. doi: 10.1007/s00392-013-0644-4. Epub 2013 Dec 20.

PMID:
24356937
14.

Trends in smoking in Canada from 1950 to 2011: progression of the tobacco epidemic according to socioeconomic status and geography.

Corsi DJ, Boyle MH, Lear SA, Chow CK, Teo KK, Subramanian SV.

Cancer Causes Control. 2014 Jan;25(1):45-57. doi: 10.1007/s10552-013-0307-9. Epub 2013 Oct 25.

PMID:
24158778
15.

Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial.

Mancini GB, Hartigan PM, Bates ER, Chaitman BR, Sedlis SP, Maron DJ, Kostuk WJ, Spertus JA, Teo KK, Dada M, Knudtson M, Berman DS, Booth DC, Boden WE, Weintraub WS.

Am Heart J. 2013 Sep;166(3):481-7. doi: 10.1016/j.ahj.2013.07.007. Epub 2013 Aug 2.

PMID:
24016497
16.

Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).

Sedlis SP, Jurkovitz CT, Hartigan PM, Kolm P, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, Boden WE, Weintraub WS; COURAGE Study Investigators.

Am J Cardiol. 2013 Dec 1;112(11):1703-8. doi: 10.1016/j.amjcard.2013.07.034. Epub 2013 Sep 3.

PMID:
24011740
17.

Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S; PURE (Prospective Urban Rural Epidemiology) Study investigators.

JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182.

PMID:
24002282
18.

Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

Acharjee S, Boden WE, Hartigan PM, Teo KK, Maron DJ, Sedlis SP, Kostuk W, Spertus JA, Dada M, Chaitman BR, Mancini GB, Weintraub WS.

J Am Coll Cardiol. 2013 Nov 12;62(20):1826-33. doi: 10.1016/j.jacc.2013.07.051. Epub 2013 Aug 21.

19.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators.

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
20.

Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial.

Teo KK, Goldstein LB, Chaitman BR, Grant S, Weintraub WS, Anderson DC, Sila CA, Cruz-Flores S, Padley RJ, Kostuk WJ, Boden WE; AIM-HIGH Investigators.

Stroke. 2013 Oct;44(10):2688-93. doi: 10.1161/STROKEAHA.113.001529. Epub 2013 Jul 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk